Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier

RFX, a rifamycin-based antibacterial agent obtained by the culture of the actinomycete Streptomyces mediterranei, has a broad antibacterial spectrum covering gram- positive, gram-negative, aerobic, and anaerobic bacteria. RFX is an antibiotic that elicits its effect by inhibiting bacterial RNA synth...

Descripción completa

Detalles Bibliográficos
Autores principales: Torre, Aldo, Córdova-Gallardo, Jacqueline, Frati Munari, Alberto C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612522/
https://www.ncbi.nlm.nih.gov/pubmed/37899985
http://dx.doi.org/10.2147/TCRM.S425292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612522/
https://www.ncbi.nlm.nih.gov/pubmed/37899985
http://dx.doi.org/10.2147/TCRM.S425292

Ejemplares similares